Albert David Ltd

Albert David Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Albert David Ltd

₹ 882 5.44%
01 Jul - close price
albertdavidindia.com BSE: 524075 NSE: ALBERTDAVD
About

Incorporated in 1938, Albert David
Ltd is in the business of manufacturing pharmaceutical products[1]

Key Points

Business Overview:[1]
ADL is a part of the Kolkata-based Kothari Group. It is a prominent drug house, which is in the field of manufacturing Pharmaceutical Formulations, Infusion Solutions, Herbal Dosage Forms, Bulk Drugs, etc. Company is in strategic liaison with academic institutes like the Indian Institute of Chemical Biology (CSIR) & Department of Biotechnology, Calcutta University for outsourcing research.

Website BSE NSE
  • Market Cap ₹ 504 Cr.
  • Current Price ₹ 882
  • High / Low ₹ 1,754 / 763
  • Stock P/E 29.3
  • Book Value ₹ 688
  • Dividend Yield 0.57 %
  • ROCE 6.48 %
  • ROE 4.44 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.

Cons

  • The company has delivered a poor sales growth of 1.57% over past five years.
  • Company has a low return on equity of 12.5% over last 3 years.
  • Earnings include an other income of Rs.29.6 Cr.
  • Dividend payout has been low at 13.2% of profits over last 3 years
  • Working capital days have increased from 94.2 days to 274 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
74 93 92 75 81 92 93 88 89 89 98 83 75
64 81 78 66 72 79 77 80 79 88 92 82 80
Operating Profit 10 12 14 8 10 13 16 8 10 1 6 1 -5
OPM % 13% 13% 15% 11% 12% 14% 17% 9% 11% 1% 6% 1% -6%
-1 -6 14 7 0 18 12 17 10 23 21 -9 -5
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 2 2 2 2 2 2 1 2 2 2 2 2 2
Profit before tax 7 4 26 14 7 29 27 23 18 22 25 -10 -12
Tax % 38% 60% 21% 22% 48% 20% 24% 20% 29% 15% 28% -8% -13%
4 2 20 11 4 23 20 19 13 19 18 -9 -10
EPS in Rs 7.31 3.08 35.29 18.49 6.54 41.16 35.57 32.80 22.62 33.01 31.66 -16.45 -18.10
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
287 317 318 293 285 316 320 246 313 341 362 346
254 281 286 266 267 286 289 227 272 297 315 343
Operating Profit 33 37 31 27 18 30 30 19 41 44 47 3
OPM % 11% 12% 10% 9% 6% 10% 10% 8% 13% 13% 13% 1%
1 2 43 8 9 15 7 17 16 15 58 30
Interest 4 3 2 1 1 1 1 1 1 1 0 0
Depreciation 11 15 9 8 8 7 8 8 9 9 7 7
Profit before tax 18 20 63 26 18 38 29 27 47 51 97 25
Tax % 32% 32% 24% 39% 45% 29% 34% 19% 25% 29% 22% 32%
13 14 48 16 10 27 19 22 35 36 75 17
EPS in Rs 22.02 24.00 84.10 27.96 17.24 46.68 33.59 38.79 61.78 63.38 132.15 30.14
Dividend Payout % 23% 23% 7% 20% 32% 13% 21% 15% 15% 14% 9% 17%
Compounded Sales Growth
10 Years: 1%
5 Years: 2%
3 Years: 3%
TTM: -4%
Compounded Profit Growth
10 Years: 2%
5 Years: -2%
3 Years: -20%
TTM: -77%
Stock Price CAGR
10 Years: 11%
5 Years: 16%
3 Years: 19%
1 Year: -35%
Return on Equity
10 Years: 11%
5 Years: 12%
3 Years: 13%
Last Year: 4%

Balance Sheet

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 6 6 6 6 6 6 6 6 6 6 6 6
Reserves 85 87 131 177 180 205 217 239 274 306 377 387
42 30 20 30 28 0 2 2 6 5 3 12
66 71 67 71 76 84 95 95 116 106 112 107
Total Liabilities 198 193 224 285 290 295 320 341 401 423 498 511
67 49 44 87 83 77 91 84 88 80 83 99
CWIP 3 5 5 9 5 5 2 1 1 3 7 2
Investments 16 16 48 59 68 113 122 138 183 193 273 260
111 122 127 130 134 99 106 119 130 148 135 151
Total Assets 198 193 224 285 290 295 320 341 401 423 498 511

Cash Flows

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
21 28 68 20 30 32 30 37 40 11 46 -28
-24 -9 -38 -36 -11 -19 -20 -37 -40 -5 -33 23
-2 -18 -18 7 -5 -17 -10 -2 -2 -6 -8 0
Net Cash Flow -5 1 12 -10 15 -4 -0 -2 -1 -1 4 -5

Ratios

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 54 47 41 41 35 25 34 29 29 32 30 29
Inventory Days 191 176 187 217 173 151 148 151 124 149 126 201
Days Payable 135 103 102 117 127 102 132 104 96 95 98 118
Cash Conversion Cycle 111 120 126 141 81 74 50 76 57 87 58 112
Working Capital Days 57 52 48 61 45 22 18 -8 -29 19 -10 274
ROCE % 18% 18% 17% 15% 7% 18% 14% 12% 17% 17% 28% 6%

Shareholding Pattern

Numbers in percentages

Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
61.99% 61.99% 61.99% 62.04% 62.04% 62.04% 62.04% 62.13% 62.13% 62.13% 62.13% 62.23%
0.64% 0.61% 0.57% 0.57% 0.65% 0.57% 0.70% 0.98% 0.80% 0.88% 0.86% 1.00%
3.17% 2.97% 2.84% 2.80% 2.30% 1.90% 1.67% 1.67% 1.67% 1.63% 1.63% 1.64%
34.19% 34.43% 34.60% 34.59% 35.01% 35.49% 35.60% 35.23% 35.41% 35.36% 35.39% 35.12%
No. of Shareholders 10,70810,38110,0109,7869,8289,90710,04111,26612,34913,59014,83015,304

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings